Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB–III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity
Titel:
Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB–III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity
Auteur:
Eggermont, Alexander M.M. Suciu, Stefan Rutkowski, Piotr Kruit, Willem H. Punt, Cornelis J. Dummer, Reinhard Salès, François Keilholz, Ulrich de Schaetzen, Gaetan Testori, Alessandro